| Product Code: ETC13203572 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Cell and Gene Therapy Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Cell and Gene Therapy Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Cell and Gene Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 North America Cell and Gene Therapy Market - Industry Life Cycle |
3.4 North America Cell and Gene Therapy Market - Porter's Five Forces |
3.5 North America Cell and Gene Therapy Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Cell and Gene Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 North America Cell and Gene Therapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 North America Cell and Gene Therapy Market Revenues & Volume Share, By Delivery Mode, 2021 & 2031F |
3.9 North America Cell and Gene Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Cell and Gene Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Cell and Gene Therapy Market Trends |
6 North America Cell and Gene Therapy Market, 2021 - 2031 |
6.1 North America Cell and Gene Therapy Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Cell and Gene Therapy Market, Revenues & Volume, By Cell Therapy, 2021 - 2031 |
6.1.3 North America Cell and Gene Therapy Market, Revenues & Volume, By Gene Therapy, 2021 - 2031 |
6.2 North America Cell and Gene Therapy Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Cell and Gene Therapy Market, Revenues & Volume, By Cardiovascular Disease, 2021 - 2031 |
6.2.3 North America Cell and Gene Therapy Market, Revenues & Volume, By Oncology Disorder, 2021 - 2031 |
6.2.4 North America Cell and Gene Therapy Market, Revenues & Volume, By Genetic Disorder, 2021 - 2031 |
6.2.5 North America Cell and Gene Therapy Market, Revenues & Volume, By Infectious Disease, 2021 - 2031 |
6.2.6 North America Cell and Gene Therapy Market, Revenues & Volume, By Neurological Disorder, 2021 - 2031 |
6.2.7 North America Cell and Gene Therapy Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Cell and Gene Therapy Market, Revenues & Volume, By Delivery Mode, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Cell and Gene Therapy Market, Revenues & Volume, By In-Vivo, 2021 - 2031 |
6.3.3 North America Cell and Gene Therapy Market, Revenues & Volume, By Ex-Vivo, 2021 - 2031 |
6.4 North America Cell and Gene Therapy Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America Cell and Gene Therapy Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Cell and Gene Therapy Market, Revenues & Volume, By Cancer Care Centers, 2021 - 2031 |
6.4.4 North America Cell and Gene Therapy Market, Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021 - 2031 |
6.4.5 North America Cell and Gene Therapy Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Cell and Gene Therapy Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Cell and Gene Therapy Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.2.1 United States (US) Cell and Gene Therapy Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.2.2 Canada Cell and Gene Therapy Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.2.3 Rest of North America Cell and Gene Therapy Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.3 North America Cell and Gene Therapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
7.3.1 United States (US) Cell and Gene Therapy Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.3.2 Canada Cell and Gene Therapy Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.3.3 Rest of North America Cell and Gene Therapy Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.4 North America Cell and Gene Therapy Market, Revenues & Volume, By Delivery Mode, 2021 - 2031 |
7.4.1 United States (US) Cell and Gene Therapy Market, Revenues & Volume, By Delivery Mode, 2021 - 2031 |
7.4.2 Canada Cell and Gene Therapy Market, Revenues & Volume, By Delivery Mode, 2021 - 2031 |
7.4.3 Rest of North America Cell and Gene Therapy Market, Revenues & Volume, By Delivery Mode, 2021 - 2031 |
7.5 North America Cell and Gene Therapy Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) Cell and Gene Therapy Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada Cell and Gene Therapy Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America Cell and Gene Therapy Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Cell and Gene Therapy Market Key Performance Indicators |
9 North America Cell and Gene Therapy Market - Export/Import By Countries Assessment |
10 North America Cell and Gene Therapy Market - Opportunity Assessment |
10.1 North America Cell and Gene Therapy Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Cell and Gene Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
10.3 North America Cell and Gene Therapy Market Opportunity Assessment, By Indication, 2021 & 2031F |
10.4 North America Cell and Gene Therapy Market Opportunity Assessment, By Delivery Mode, 2021 & 2031F |
10.5 North America Cell and Gene Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Cell and Gene Therapy Market - Competitive Landscape |
11.1 North America Cell and Gene Therapy Market Revenue Share, By Companies, 2022 |
11.2 North America Cell and Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here